Opus Point Partners Management Stake in Bristol Myers Squibb Co (BMY) Lifted as Stock Rose; Acadian Asset Management Lowered Its Holding in General Dynamics (GD) by $1.38 Million as Stock Value Rose

April 25, 2018 - By Stephen Andrade

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Acadian Asset Management Llc decreased its stake in General Dynamics Corp (GD) by 68.47% based on its latest 2017Q4 regulatory filing with the SEC. Acadian Asset Management Llc sold 6,811 shares as the company’s stock rose 9.09% while stock markets declined. The institutional investor held 3,137 shares of the marine transportation company at the end of 2017Q4, valued at $639,000, down from 9,948 at the end of the previous reported quarter. Acadian Asset Management Llc who had been investing in General Dynamics Corp for a number of months, seems to be less bullish one the $64.05B market cap company. The stock decreased 3.22% or $7.14 during the last trading session, reaching $214.88. About 2.55M shares traded or 56.87% up from the average. General Dynamics Corporation (NYSE:GD) has risen 19.18% since April 25, 2017 and is uptrending. It has outperformed by 7.63% the S&P500.

Opus Point Partners Management Llc increased its stake in Bristol Myers Squibb Co (BMY) by 100% based on its latest 2017Q4 regulatory filing with the SEC. Opus Point Partners Management Llc bought 45,000 shares as the company’s stock rose 2.38% while stock markets declined. The institutional investor held 90,000 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $5.52M, up from 45,000 at the end of the previous reported quarter. Opus Point Partners Management Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be bullish on the $83.70 billion market cap company. The stock decreased 0.76% or $0.39 during the last trading session, reaching $51.19. About 6.40M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since April 25, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Since December 12, 2017, it had 1 insider buy, and 1 insider sale for $85,985 activity. 4,000 shares were bought by Samuels Theodore R. II, worth $249,187 on Friday, December 15.

Opus Point Partners Management Llc, which manages about $115.61 million US Long portfolio, decreased its stake in Gilead Sciences Inc (NASDAQ:GILD) by 6,925 shares to 3,075 shares, valued at $220,000 in 2017Q4, according to the filing. It also reduced its holding in Neurocrine Biosciences Inc (NASDAQ:NBIX) by 5,440 shares in the quarter, leaving it with 4,204 shares, and cut its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY).

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.09, from 1.03 in 2017Q3. It fall, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Barclays Pcl accumulated 2.67 million shares or 0.13% of the stock. Fiera Capital Corporation stated it has 0% in Bristol-Myers Squibb Company (NYSE:BMY). Alphaone Invest Ltd Com holds 0.02% or 983 shares. Advsrs Incorporated Ok invested in 155,610 shares. Curbstone Management reported 0.2% stake. Reliance Company Of Delaware stated it has 0.52% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Parsons Capital Management Ri has 0.41% invested in Bristol-Myers Squibb Company (NYSE:BMY). British Columbia – Canada-based Connor Clark & Lunn Inv Management has invested 0.16% in Bristol-Myers Squibb Company (NYSE:BMY). Chilton Ltd Co, Connecticut-based fund reported 5,157 shares. Cypress Capital Mngmt Limited Liability Corporation (Wy) has 1,350 shares. Susquehanna Intll Grp Inc Llp accumulated 152,354 shares. Moreover, Barrett Asset Ltd has 1.26% invested in Bristol-Myers Squibb Company (NYSE:BMY). Mechanics Financial Bank Trust Department owns 116,946 shares. Villere St Denis J Limited Liability Corp accumulated 5,000 shares or 0.02% of the stock. Fort Washington Investment Advsrs Oh reported 1.47% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY).

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 12 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 84 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, December 2 by Guggenheim. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Jefferies on Thursday, November 16. Piper Jaffray maintained the stock with “Hold” rating in Friday, September 22 report. UBS maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Friday, April 29. UBS has “Buy” rating and $80 target. As per Monday, July 17, the company rating was maintained by Jefferies. The stock has “Market Perform” rating by BMO Capital Markets on Wednesday, April 5. The rating was maintained by Jefferies on Friday, September 15 with “Buy”. The stock has “Equal-Weight” rating by Morgan Stanley on Tuesday, April 17. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by SunTrust on Monday, October 30. The firm has “Hold” rating by Cowen & Co given on Monday, July 10.

Since February 14, 2018, it had 0 insider buys, and 8 insider sales for $8.28 million activity. 3,933 shares were sold by Johnson S. Daniel, worth $899,843. Shares for $389,574 were sold by KEANE JOHN M. $814,050 worth of General Dynamics Corporation (NYSE:GD) was sold by Roualet Mark C. on Tuesday, February 27. $931,045 worth of General Dynamics Corporation (NYSE:GD) shares were sold by CASEY JOHN PATRICK. Whited Gary L sold $1.34 million worth of stock.

Among 22 analysts covering General Dynamics Corporation (NYSE:GD), 14 have Buy rating, 2 Sell and 6 Hold. Therefore 64% are positive. General Dynamics Corporation had 76 analyst reports since July 31, 2015 according to SRatingsIntel. The company was maintained on Thursday, October 29 by Wolfe Research. As per Thursday, January 28, the company rating was maintained by RBC Capital Markets. Cowen & Co maintained the stock with “Buy” rating in Monday, September 18 report. RBC Capital Markets maintained General Dynamics Corporation (NYSE:GD) on Friday, August 11 with “Buy” rating. The rating was maintained by Goldman Sachs on Monday, May 2 with “Neutral”. The firm has “Outperform” rating given on Monday, January 30 by RBC Capital Markets. Zacks downgraded General Dynamics Corporation (NYSE:GD) on Tuesday, August 25 to “Buy” rating. On Thursday, January 25 the stock rating was maintained by Bank of America with “Buy”. Citigroup maintained it with “Neutral” rating and $235 target in Thursday, January 25 report. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, October 8 report.

Acadian Asset Management Llc, which manages about $65.15B and $23.06B US Long portfolio, upped its stake in Align Technology Inc (NASDAQ:ALGN) by 106,093 shares to 111,969 shares, valued at $24.88 million in 2017Q4, according to the filing. It also increased its holding in Monarch Casino & Resort Inc (NASDAQ:MCRI) by 40,540 shares in the quarter, for a total of 51,402 shares, and has risen its stake in Procter And Gamble Co (NYSE:PG).

General Dynamics Corporation (NYSE:GD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: